论文部分内容阅读
由全国疟疾防治领导小组主持的抗疟新药硝喹及复方硝喹片鉴定会,于1979年10月5日至8日在第三军医大学召开。 这次鉴定的硝喹及复方硝喹片,是第三军医大学与上海医药工业研究院共同研制的。自1971年合成以来,通过大量的动物试验,药理、毒理观察,健康人试服及临床试用,证明该药对鼠疟、鸡疟、猴疟的红细胞内期和组织期都有较好的抗疟作用,并对鸡疟、猴疟在蚊体孢子增殖期有阻断作用;在药物的代谢、致
The identification of the compound anti-malaria drug quinolizarin and compound quinolizarin tablets, chaired by the national malaria control leading group, was held at the Third Military Medical University from October 5 to October 1979. The identification of nitrate and compound nitrate Quinidine tablets, is the Third Military Medical University and Shanghai Institute of Pharmaceutical Industry co-developed. Since its synthesis in 1971, it has been proved that this medicine has good erythrocytic end stage and tissue stage of malaria, malaria, and malaria by a large number of animal experiments, pharmacological and toxicology observation, healthy human test and clinical trial Anti-malarial effect, and malaria, malaria in the mosquito spore proliferation phase has a blocking effect; in the metabolism of drugs, caused